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Streptococcus suis type 2 (SS2) is a zoonotic pathogen causing septic infection,
meningitis and pneumonia in pigs and humans. SS2 may cause streptococcal toxic
shock syndrome (STSS) probably due to excessive release of inflammatory cytokines. A
previous study indicated that the virD4 gene in the putative type IV-like secretion system
(T4SS) within the 89K pathogenicity island specific for recent epidemic strains contributed
to the development of STSS. However, the functional basis of VirD4 in STSS remains
unclear. Here we show that deletion of virD4 led to reduced virulence as shown by about
65% higher LD50, lower bacterial load in liver and brain, and lower level of expression of
inflammatory cytokines in mice and cell lines than its parent strain. The 1VirD4 mutant
wasmore easily phagocytosed, suggesting its role as an anti-phagocytic factor. Oxidative
stress that mimic bacterial exposure to respiratory burst of phagocytes upregulated
expression of virD4. Proteomic analysis identified 10 secreted proteins of significant
differences between the parent andmutant strains under oxidative stress, including PrsA,
a peptidyl-prolyl isomerase. The SS2 PrsA expressed in E. coli caused a dose-dependent
cell death and increased expression of proinflammatory IL-1β , IL-6 and TNF-α in murine
macrophage cells. Our data provide novel insights into the contribution of the VirD4
factor to STSS pathogenesis, possibly via its anti-phagocytic activity, upregulation of
its expression upon oxidative stress and its involvement in increased secretion of PrsA
as a cell death inducer and proinflammatory effector.
Keywords: Streptococcus suis type 2, streptococcal toxic shock syndrome, VirD4, anti- phagocytic, PrsA,
inflammatory response
INTRODUCTION
Streptococcus suis type 2 (SS2) is a major swine pathogen and an emerging zoonotic agent, causing
meningitis, arthritis, septicemia and pneumonia in humans and pigs (Lun et al., 2007; Gottschalk
et al., 2010; Feng et al., 2014). S. suis type 2 was initially seen to cause only sporadic cases of
meningitis and sepsis in humans working with pigs or pork-derived products (Wertheim et al.,
2009). However, two outbreaks of human SS2 infection in China in 1998 and in 2005 raised
considerable concerns among public health professionals (Tang et al., 2006). Infection in these
two outbreaks was characterized by acute high fever, clear systemic erythematous blanching rash,
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disseminated intravascular coagulation and multiple organ
failure and shock as well as short duration of the disease (acute
death within hours of infection) and high mortality (Sriskandan
and Slater, 2006; Tang et al., 2006).
Streptococcus suis type 2 isolates of these two outbreaks
exhibit strong invasiveness and high pathogenicity leading to a
new disease form as streptococcal toxic shock syndrome (STSS)
which was originally referred to S. pyogenes (GAS) (Feng et al.,
2010). The main virulence factors involved in S. pyogenes STSS
consist of so-called superantigens or molecules that trigger non-
specific, uncontrolled activation of T cells and massive cytokine
release. Although a collection of new virulence factors have
been described in SS2, there were no superantigen candidates
identified so far, implying that a different mechanism could be
involved in the STSS form caused by SS2 variant strains from
these two outbreaks (Tang et al., 2006; Lappin and Ferguson,
2009; Feng et al., 2010). Comparative genomics analysis has
revealed that a functional pathogenicity island (PAI) of about
89 kb (89K) is exclusively present in the epidemic strains in
the two Chinese SS2 outbreaks but not in other clinical isolates
(Chen et al., 2007; Feng et al., 2011). Further studies suggested
that 89K PAI with a transposon-like essence could undergo GI-
type (genomic island) T4SS (type IV secretion system)-mediated
horizontal transfer and encodes at least two sets of genetic
elements involved in SS2 virulence: a salK-salR two-component
regulation system and a type IV-like secretion system (T4SS-like)
(Zhao et al., 2011).
Another specific feature for STSS caused by SS2 variant
isolates from the outbreaks was an early phase excessive burst
of proinflammatory cytokines storm (Ye et al., 2009; Fittipaldi
et al., 2012; Lachance et al., 2013). Such an unbalanced immune
response could be harmful not only to the pathogens but also
to the host. Such excessive inflammation is responsible for high
mortality observed in STSS cases. A recent study illustrated that
deletion of the key component (VirD4 or VirB4) of the T4SS-
like system led to decreased virulence and alleviation of excessive
systemic inflammatory responses in mice (Zhao et al., 2011).
However, the functional mechanisms of the T4SS-like system
(including VirD4) in SS2 infection are still poorly understood.
This study was aimed to investigate the roles of VirD4
in microbe-host interaction and to explore possible effectors
contributing to the pathogenicity of S. suis type 2 infection.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
Streptococcus suis type 2 strain HA9801, kindly donated by
Professor C. Lu (Nanjing Agricultural University, China), was an
isolate from the Jiangsu outbreak of STSS in 1998. Its isogenic
mutant with deletion of virD4 ORF (1VirD4) was constructed
using the pSET4s vector kindly provided by D. Takamatsu
(National Institute of Animal Health, Japan) (Takamatsu et al.,
2001). Deletion of the target gene was confirmed by PCR with
flanking, internal and external primers (Figure S1). The SS2
strains were grown in Brain Heart Infusion (BHI) (Oxoid,
England) at 37◦C with shaking at 180 rpm. Escherichia coliDH5a
and BL21 (TransGen, Beijing) were grown in Luria broth media
(Oxoid, England).
Virulence in Murine Model
A mouse infection model was used to compare virulence
between 1VirD4 mutant and its parent strain (or wild-type
strain, WT). Bacterial cultures were adjusted to OD600 0.4 with
PBS (equivalent to about 3–5 × 108 CFU/ml). 6-week old
female BALB/c mice, eight for each strain, were infected by
intraperitoneal injection of the two strains in 1.0 ml volume of
the PBS dilutions containing 1.8 × 108 to 1.2 × 109 CFU. Mice
inoculated with sterile PBS were included as control. Mortality
was monitored every day for 7 days post-infection (dpi). The 50%
lethal dose (LD50) was calculated using the Reed and Muench
method. To compare bacterial load in organs, mice (six for each
strain) were inoculated intraperitoneally with 4.3–4.5× 108 CFU.
Mice were humanely euthanized at 12 h post-infection (hpi).
Spleen, liver and brain samples were collected, homogenized and
diluted for plate counting on BHI agar plates.
Survival in Murine Blood
To examine the contribution of VirD4 in survival, Mouse whole
blood survival assay was conducted as previously described (Liu
et al., 2014). Briefly, 50 µl of the WT and 1VirD4 strains
at logarithmic phase adjusted to 0.4 in PBS were inoculated
into sterile Eppendorf tubes pre-filled with 450 µl of fresh
anticoagulant whole blood pooled from clinically healthy mice.
The blood-bacteria mixtures were incubated with shaking at
180 rpm at 37◦C for 1 h. Surviving bacteria were then diluted and
plated on BHI agar plates for enumeration. Survival percentage
was calculated as (CFU on plate/CFU in initial inoculum) ×
100%.
Phagocytosis Assay
Phagocytosis assay was performed as previously described
(Feng et al., 2012) in four types of cells, i.e., primary bone
marrow macrophages (BMDM) from C57BL/6 mice (Hu et al.,
2014), mouse macrophage cell lines RAW264.7, porcine alveolar
macrophage 3D4/2 (PAM 3D4/2) and human monocytic cell
line THP-1. Briefly, cells (2–2.5 × 105 cells) grown in DMEM
or 1640 medium (Gibco, Invitrogen, Germany) were infected at
a multiplicity of infection (MOI) of 100 for 1 h. The infected
monolayers were washed twice with warm PBS and re-incubated
for another hour in the medium containing gentamicin (300
µg/ml) (Sigma-Aldrich, Ontario, Canada) to kill extracellular
bacteria. Cultures were then washed four times with PBS and
replaced with 1 ml of sterile distilled water to lyse cells.
Viable intracellular bacteria were determined by plating of serial
dilutions of the lysates on BHI agar. This assay was repeated
at least four times with each strain tested in triplicate wells
in independent experiments. Double immuno-fluorescence was
performed to visualize phagocytosis as previously described
(Benga et al., 2004). The RAW264.7 or BMDM cells were
infected as above and washed three times with PBS. The cells
were fixed for 10 min with 4% paraformaldehyde in PBS
and blocked for 1 h with 10% inactivated fetal bovine serum
in PBS. The macrophage cells were then sequentially probed
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with rabbit anti-S. suis antibody (1:100) for 1 h and TRITC-
conjugated goat anti-rabbit IgG antiserum (1:50, Boster, China)
for 1 h to stain extracellular bacteria. Afterwards, cells were
washed with PBS and permeabilized with 0.2% Triton X-100
for 15 min. Total cell-associated bacteria were identified by
staining of permeabilized cells with the same primary antibody
followed by FITC-conjugated goat anti-rabbit IgG antibody for
1 h. Samples were analyzed with 600-fold magnification on an
IX-81 confocal microscope integrated into the FV-1000 imaging
system (Olympus, Hamburg, Germany).
Analysis of Proinflammatory Cytokines
BALB/c mice (four mice per strain at each time point) were
inoculated intraperitoneally with sublethal dose (2.1–3.3 × 108
CFU) of WT and 1VirD4 strains. Mice injected with sterile
PBS were included as control. Spleen, brain and blood samples
were collected at 6, 12, and 24 hpi. Total RNA samples from
spleens and brains were isolated using animal tissue total RNA
isolation kit (TIANGEN, Beijing) and used for cDNA synthesis
with AMV reverse transcriptase reaction kit (TOYOBO, Japan)
according to the manufacturer’s instructions. Quantitative PCR
(qPCR) was performed to measure the transcriptional levels of
proinflammatory cytokines (IL-β, IL-6, TNF-α andMCP-1) using
the SYBR green PCR Kit (TOYOBO) and the Agligent MX3000P
qPCR system (Stratagene, USA). Additionally, macrophage cell
lines RAW264.7 and 3D4/2 were infected at MOI of 100 for 2 h.
Total RNA isolation, cDNA synthesis and qPCR were conducted
as described above. All primers used for qPCRwere listed in Table
S1. β-actin was used as the reference gene for normalization.
Results were presented as fold changes relative to non-infected
cells using the 2−11Ct method. IL-1β and IL-6 cytokines in
serum samples were determination by ELISA kits (ExCell,
Shanghai).
Analysis of Secreted Protein Profiles and
Vird4 Expression of S. suis Type 2 Exposed
to Hydrogen Peroxide Stress or in Infected
Macrophages
Pathogenic bacteria are faced with oxidative stress during
infection as a result of respiratory burst of the phagocytic cells.
To mimic such oxidative stress, theWT and1VirD4 strains were
cultured at 37◦C in BHI with or without 10mM H2O2. Bacterial
cells were collected at late logarithmic phase. Total bacterial RNA
was extracted for cDNA synthesis with the reverse transcriptase
reaction kit (TOYOBO). qPCR was performed to measure the
mRNA level of the virD4 gene using specific primers (Table
S1). To examine the role of cellular effects in virD4 expression,
RAW264.7 cells were infected with the wild-type strain (MOI
100 for 2 h) in the presence or absence of a reactive oxygen
species inhibitor (N-acetyl-l-cystein, NAC, 5 mM). Two parts
of the bacterial population were collected for qPCR analysis
of virD4 mRNA: bacteria adhered to and phagocytosed by
the macrophages (cell-associated) and unassociated supernatant
bacteria (bacteria in culture supernatant). To analyze possible
involvement of VirD4 in protein secretion uponH2O2 treatment,
culture supernatant samples of both the WT and1VirD4 strains
were prepared as previously reported (Geng et al., 2008). Briefly,
culture supernatants at late logarithmic phase BHI cultures with
or without H2O2 treatment were harvested by centrifugation
(8000 rpm for 20 min at 4◦C), treated with a protease inhibitor
PMSF (Phenylmethanesulfonyl fluoride) (Beyotime, Shanghai)
and filtered through a 0.22-µmmembrane. The secreted proteins
were precipitated with 10% trichloroacetic acid (TCA) in acetone
for 1 h on ice and collected by centrifugation at 10,000 × g
for 20 min at 4◦C. The precipitates were washed 3 times with
ice-cold acetone containing 0.1% PMSF and air-dried. Proteins
were quantified with the BCA kit (Beyotime, Shanghai). The
protein samples (30 µg per lane) were subjected to SDS-PAGE
followed by Coomassie blue R250 staining or byWestern blotting
using rabbit anti-SS2 whole cell polyclonal antibodies (1:300)
and HRP-conjugated goat anti-rabbit secondary antibodies.
Protein bands were visualized using the chemi-luminescence
substrate (Thermo, USA) and chemiluminescent imaging system
(SageCreation, Beijing).
Identification of Secreted Proteins by
2D-Page and LC-MS/MS
The above protein samples were further treated with a 2D
Clean-Up kit (Bio-Rad), resuspended in lysis buffer and then
quantified for equal loading. Two dimensional electrophoresis
(2DE) and identification of proteins by mass spectrometry
(Bruker Dalton, Ultraflex III TOF/TOF) were performed as
described elsewhere (Jing et al., 2008). Comparison of secreted
protein spots was performed with the ImageMaster 2D platinum
5.0 (GE Healthcare, Uppsala, Sweden). Only spots with relative
high abundance showing consistent and reproducible changes
(>3 folds) in 2D-gels were excised and subjected to mass
spectrometry. FlexAnalysis software (Bruker Dalton) was used to
remove contaminant peaks (including matrix peaks and solvent
peaks). Peptide mass fingerprinting (PMF) data was analyzed
using the MASCOT server (http://www.matrixscience.com) to
search for target proteins from the S. suis protein sequence data
in the NCBI database.
Transcriptional Analysis of the Genes
Encoding Differentially Secreted Proteins
upon Oxidative Stress
Procedures for oxidative stress, total RNA extraction from the
WT and 1VirD4 strains and cDNA synthesis were described
above. qPCR was conducted using specific primers (Table S1) to
evaluate transcriptional levels of the genes encoding significantly
upregulated or downregulated proteins between WT and
1VirD4 strains. The 16S rRNA gene was tested in parallel for
normalization.
Expression of Recombinant PrsA Protein
and Antiserum Preparation
The PrsA gene was PCR-amplified from the genome DNA of the
strain HA9801 using specific primers (Table S1), digested with
corresponding restriction enzymes, and cloned to pET-30a vector
for expression in E. coli BL21. The recombinant protein was
purified using Ni-NTA columns (Novagen). Lipopolysaccharides
in the purified protein were removed using a ToxinEraserTM
Endotoxin Removal Kit (Genscript, USA), and tested using a
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Chromogenic LAL Endotoxin Assay Kit (GenScript, USA). The
protein was then passed through a 0.22-µm filter, concentrated
by membrane ultrafiltration (Millipore) and stored at −80◦C.
The BCA protein assay kit (Beyotime) was used to determine
the protein concentration. SDS-PAGE and Western blotting
were performed to confirm presence of the target protein with
an anti-His monoclonal antibody (Sungene Biotech, China).
Hyperimmune sera to PrsA were obtained from New Zealand
White rabbits after four times of subcutaneous immunization
at a 2-week interval with 200 µg of purified recombinant PrsA
emulsified with Freund’s complete (primary immunization) or
incomplete adjuvant (booster immunization). Anti-PrsA sera
were collected and had titers >1:10000 as measured by ELISA.
Preimmune serum samples were collected as negative control. In
order to measure the relative abundance of PrsA in the culture
supernatants of the WT and 1VirD4 strains treated with or
without hydrogen peroxide, the extracted protein samples (3
µg/well) were coated onto the 96-wells and probed with rabbit
anti-PrsA polyclonal antibodies for indirect ELISA.
Investigation of PrsA Protein Functions
Cell cytotoxicity of PrsA was conducted as previously described
(Jiang et al., 2016). The mouse brain microvascular endothelial
cell line bEND3.0 cultured in DMEM supplemented with 10%
FBS (Gibco, USA) were stimulated with purified PrsA at different
concentrations and incubated for 1 or 2 h at 37◦C with 5%
CO2. PBS and 0.2% Triton X-100 treatments served as negative
and positive controls, respectively. Cytotoxicity was qualified by
Lactate Dehydrogenase Cytotoxicity Assay Kit (Beyotime, China)
or observed directly under fluorescent microscope (×100) after
staining with Live/Dead cytotoxic kit (Invitrogen, Eugene, OR).
Hemolysis assay was conducted as elsewhere described
(Zheng et al., 2011). Purified PrsA protein was added to 2%
sheep red blood cells in PBS at final concentration of 50
and 100 µg per ml. The mixtures were incubated for 1 h at
37◦C with 5% CO2. After brief centrifugation at 800 g for 10
min, supernatant samples were measured at OD540 on the
SpectraMaxM2 Microplate reader (Molecular Devices, USA).
Erythrocytes withHis-tag, bovine serum albumin or 0.2%Triton-
100 and those without any treatment served as controls.
To analyze whether PrsA could induce release of pro-
inflammatory cytokines, RAW264.7 cells (2–2.5 × 105 cells)
were seeded into 24-well cell culture plates (Corning, USA)
and incubated in DMEM with 10 µg/ml of PrsA or 400 ng/ml
LPS (positive control) and without treatment (DMEM only as
negative control) at 37◦C with 5% CO2. Culture supernatants
were collected at indicated times for determination of IL-1β
and TNF-α using commercially available ELISA Max Deluxe
kits (Biolegend, USA). These two cytokines and IL-6 were also
analyzed at the transcriptional level by qPCR as described above.
Animal Ethics
All animal experiments were conducted following the
International Guiding Principles for Biomedical Research
Involving Animals-1985 and approved protocols of the
Laboratory Animal Management Committee of Zhejiang
University (Approval No. 2015016).
Statistical Analysis
All experiments were performed in triplicate and repeated at least
three times. Experimental results were expressed as mean ± SD
unless otherwise stated. Data were subjected to normality tests
and analyzed using two-tailed Student’s t-test with P values<0.05
or 0.01 considered as significant.
RESULTS
VirD4 Played a Role in Virulence of S. suis
Type 2
To determine the role of VirD4 in virulence, an isogenic mutant
with deletion of virD4-ORF (1VirD4) was constructed from the
wild-type strain HA9801 (Figure S1). Deletion of virD4 did not
affect growth in BHI broth with or without hydrogen peroxide
treatment, as compared with its parent strain (Figure 1A and
Figure S2). With BALB/c mouse infection model, we found that
VirD4 contributed to virulence as shown by about 65% higher
LD50 (Figure 1B) and lower bacterial load in liver and brain
(P< 0.05; Figure 1C) than its parent strain. The1VirD4 mutant
was also more susceptible to bactericidal effect of the whole blood
than the wild-type strain (P < 0.01, Figure 1D).
VirD4 Was Anti-Phagocytic
Phagocytic cells serve as the first line of host defense against
invading bacterial pathogens. We investigated whether VirD4
could play roles in phagocytosis using murine BMDM and
RAW264.7, porcine PAM 3D4/2 cells as well as human derived
THP-1 cells. Surprisingly, deletion of virD4 rendered the bacteria
more easily phagocytosed, particularly in BMDM (Figure 2A).
Double label immuno-fluorescence assay further verified this
phenomenon (Figure 2B). These findings indicated that VirD4
might be an anti-phagocytic factor.
Deletion of VirD4 Decreased Expression of
Inflammatory Cytokines
To determine whether VirD4 is involved in expression of
proinflammatory cytokines, serum or organ samples were
collected from intraperitoneally infected mice for analysis
of proinflammatory cytokines. Figure 3 showed that S. suis
could induce a rapid proinflammatory systemic response in
mice with systemic cytokine and chemokine release. The
transcriptional levels of IL-6, TNF-a, IL-1β and MCP-1 were
remarkably increased in the early stage of infection (within
12 h) and gradually decreased to their basal levels by 24 hpi
(Figures 3A–C). IL-6, TNF-a, and MCP-1 levels induced by WT
strain were obviously higher than 1VirD4 strain infection at
12 hpi. Because the bacterial load of the WT strain was higher
than that of the virD4 mutant in the mice brain (Figure 1C),
the observed differences in mRNA transcripts of cytokines in
mice brain could be attributed partly to bacterial load. Serum
levels of IL-6 and IL-β in mice infected with 1VirD4 strain at
6 hpi were significantly lower than those infected with the WT
strain (Figure 3D). Proinflammatory cytokines from RAW264.7
and PAM3D4/2 macrophage cells infected with 1VirD4 strain
were also lower than the WT strain at the transcriptional level,
specifically for IL-1β and IL-6 (Figure 3E).
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FIGURE 1 | The 1VirD4 mutant was less virulent than the wild-type strain. (A) Growth curves of the wild-type (WT) S. suis type 2 strain HA9801 and 1VirD4
mutant. Both strains were cultured in BHI broth and optical density was measured over a 12-h period. (B) 50% lethal dose of WT and 1VirD4 strains. Different levels
of bacteria were intraperitoneally inoculated into BALB/c mice and observed for mortality over a 1-week period. (C) Bacterial load in mice organs (n = 6) at 12 h after
sublethal intraperitoneal infection with WT and 1VirD4 strains. Each point represents a single sample. (D) Survival of WT and 1VirD4 strains in mice blood for 1 h.
Data were shown as mean ± SD of three repeated experiments, each in triplicate tubes, * at P < 0.05 or **P < 0.01.
Oxidative Stress Activated VirD4 Factor
and Deletion of virD4 Changed Profiles of
Secreted Proteins
Early studies identified some S. suis type 2 proteins induced
in vivo, including the T4SS-like VirD4 component using the
in vivo-induced antigen technology (IVIAT) (Gu et al., 2009;
Li et al., 2013). One of the major in vivo factors that the
invading bacteria encounter is reactive oxygen species (ROS,
including hydrogen peroxide) resulting from respiratory burst
(Forman and Torres, 2002; Fittipaldi et al., 2012). We attempted
to mimic in vivo environment by exposing the WT and 1VirD4
strains to H2O2 added to the BHI medium at 10mM with a
sub-inhibitory effect on growth in the pilot test (Figure S2).
The virD4 mRNA level was about 50 folds higher after H2O2
stress (Figure 4A, P < 0.001), indicating that VirD4 could be
an in vivo induced gene. Figure 4B shows that virD4 mRNA
in cell-associated bacteria was significantly higher than that of
mock control (P < 0.05), a finding similar to oxidative stress
assay (Figure 4A). Treatment of the cells with ROS inhibitor
(N-acetyl-l-cystein, NAC at 5mM) reduced virD4 expression
(P < 0.05). Thus, we believe that up-regulation of virD4 mRNA
is mainly due to oxidative stress. There were also significant
differences of secreted proteins between WT and1VirD4 strains
exposed to H2O2 as shown by Western blot and SDS-PAGE
(Figure 4C). These findings prompted us to use two dimensional
gel electrophoresis to separate the supernatant proteins of
WT and 1VirD4 strains exposure to H2O2. The differentially
expressed proteins with high abundance weremarked in 2DE gels
for further identification by mass spectrometry (Figure 4D).
Confirmation of the Selected Differentially
Secreted Proteins by qPCR
Table 1 showed that 148 protein spots were upregulated in
the 1VirD4 strain exposed to hydrogen peroxide stress while
only 33 protein spots with 1.5-fold or higher upregulation
in the WT strain. Mass spectrometry was used to identify
protein spots of significant upregulation: four spots were
identified as parvulin-like peptidyl-prolyl isomerase (PrsA),
succinate dehydrogenase (SucD), and glycerate-dependent
phosphoglycerate mutase (GpmA) in the WT strain with spots
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FIGURE 2 | Deletion of virD4 rendered the bacteria more easily
phagocytosed by murine or porcine macrophage cell lines. (A) Primary
bone marrow macrophages (BMDM) from C57BL/6 mice and murine
macrophage cell line RAW264.7, porcine alveolar macrophage (PAM) 3D4/2
and human monocytic cell line THP-1 were infected with wild-type (WT) S. suis
type 2 or 1VirD4 mutant strains (MOI at 100) for 2 h, respectively. After 1 h
treatment with gentamicin, phagocytosed bacteria were counted on BHI agar
plates. All experiments were repeated at least three times (each in triplicate
samples) and showed similar trends. Data were shown as mean ± SD of three
replicate wells of a typical experiment. “*” or “**” indicated significant at
P < 0.05 or P < 0.01, respectively. (B) Immunofluorescence for observation of
phagocytosed bacteria. Bacteria were stained by rabbit anti-SS2 whole cell
serum. Extracellular and intracellular bacteria were distinguished by red
(TRITC) and green (FITC)-colored secondary antibody staining. Bar scale
indicated were 10 µm.
B13 and B14 representing isoforms of the same protein PrsA
(Table 2). Nine spots were determined in the 1VirD4 strain as
ribonucleoside-diphosphate reductase (RNR), 6-phospho-beta-
galactosidase (LacG), uracil phosphoribosyltransferase (UPP),
galactose-6-phosphate isomerase subunit (LacB), arginine
deiminase (arcA), ornithine carbamoyltransferase (arcB) and
tagatose-bisphosphate aldolase (LacD). The spots A39 and
A40 or those of A120 and A121 represent isoforms of LacG
or LacD, respectively. These proteins were mainly involved
in DNA damage repair, nucleotide biosynthesis, carbohydrate
metabolism and stress modulation. These up-regulated proteins
were confirmed by qPCR (Table 2).
PrsA Induced Epithelial Cells Death and
Was a Novel Proinflammatory Factor in
S. suis Type 2
Among the 10 proteins of significant difference, PrsA that is
known to be involved in protein secretion and folding was
nearly 3 to 9-fold lower in the VirD4 deletion mutant than its
parent strain. To explore its functions, the PrsA protein was
expressed in soluble form in E. coli and purified to homogeneity
(Figures 5A,B) with effective removal of endotoxin (less than
0.2 endotoxin units per milliliter). Western blotting and ELISA
indicated that deletion of virD4 reduced the expression of
PrsA only upon exposure to hydrogen peroxide (Figures 5C,D).
Significant cytotoxicity to bEND3.0 cells was observed with PrsA
protein level above 75 µg/ml (Figures 6A,B). However, PrsA
did not have hemolytic activity (Figure 6C). RAW264.7 cells
stimulated with PrsA at a concentration of 10 µg/ml showed
a time-dependent increase of the proinflammatory cytokines
as examined by qPCR (IL-1β, IL-6, and TNF-α) (P < 0.01,
Figures 7A–C) and ELISA (IL-1β and TNF-α) (P < 0.01,
Figures 7D,E).
DISCUSSION
Of 35 S. suis serotypes, SS2 has emerged as an important
zoonotic agent and causes unusual outbreak of streptococcal
toxic-shock-like syndrome (STSS) (Gottschalk et al., 2010; Feng
et al., 2014). Type IV secretion system (T4SS) is a versatile
secretion system important for virulence and even survival of
some bacterial species. It was once believed to be present only
in Gram-negative bacteria but was recently identified in Gram-
positive S. suis type 2 strains causing STSS outbreaks in China
(Wallden et al., 2010). This putative SS2-T4SS is contained
in the 89K pathogenicity island and proposed as a new T4SS
subgroup (Type-IVC secretion system) (Zhang et al., 2012).
T4SS contains a channel enabling secretion of proteins and
DNA molecules across the cell envelope. This translocation
is driven by a number of cytoplasmic ATPases that energize
conformational changes in the translocation complex. VirD4
is considered as a key coupling protein that could recruit
substrates to T4SS for translocation (Wallden et al., 2010;
Trokter et al., 2014). In Helicobacter pylori, VirD4 presumably
acts as an adapter protein guiding CagA into the transport
channel and may play a role in inducing host pro-inflammatory
responses in both VirD4-CagA-dependent and VirD4-CagA-
independent mechanisms (Selbach, 2002). Here we show that
VirD4 play important roles in SS2 infection, such as evasion
from phagocytosis and increased release of proinflammatory
cytokines.
Deletion of the virD4 gene decreased SS2 virulence in mice,
as shown by higher LD50 value, lower bacterial load in organs
and reduced survival in fresh mouse blood. These virulence
phenotypes were similar to the previous findings of another
SS2 strain (05ZYH33) with virD4 deletion (Zhao et al., 2011).
However, we found that SS2-VirD4 had a novel antiphagocytic
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FIGURE 3 | Deletion of virD4 led to reduced proinflammatory responses in S. suis type 2 infected mice or cultured cells. (A–C) Transcriptional analysis of
selected proinflammatory cytokines in spleen and brain from BALB/c mice infected with infected with a sublethal dosage of wild-type (WT) S. suis type 2 or 1VirD4
mutant strains at 6, 12, and 24 hs (n = 4 per strain at each time point). (D) IL-1β and IL-6 levels in serum samples of BALB/c mice (n = 4 per strain) at 6 hs after
infection measured by ELISA. (E) Relative transcriptional levels of inflammatory associated cytokines in murine or porcine cell lines by qPCR. The results are presented
as fold induction relative to non-infected cells against β-actin gene expression using 2−11Ct method. Murine RAW264.7 or porcine PAM 3D4/2 macrophage cells
were stimulated by wild-type (WT) S. suis type or 1VirD4 mutant strains (MOI = 100) for 2 hs, respectively. Data were shown as mean ± SD of three experiments.
“*” or “**” indicated significant at P < 0.05 or P < 0.01, respectively. MCP-1, monocyte chemotactic protein-1.
function as evidenced by increased number of bacterial cells
in phagocytic cell lines upon virD4 deletion. In H. pylori,
putative T4SS core components virB7 and virB11 (ATPase
essentially similar to VirD4) were antiphagocytic (Ramarao
et al., 2000; Tegtmeyer et al., 2011). Thus, we assume that
VirD4 is involved in S. suis virulence possibly by evasion from
phagocytosis.
Once S. suis colonization and invasion of epithelial cells of the
respiratory tract and entry to the systemic circulation or deep
tissues, SS2 faces phagocytosis by neutrophils and macrophages,
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FIGURE 4 | The virD4 gene was induced by hydrogen peroxide treatment and its deletion could induce differentially secreted protein profiles between
wild-type (WT) S. suis type 2 and 1VirD4 strains subjected to oxidative stress. (A) The virD4 mRNA level from the wild-type S. suis type 2 strain subjected to
hydrogen peroxide treatment. **Indicated significant at P < 0.01. (B) The virD4 mRNA transcripts of the cell-associated bacteria and unassociated supernatant
bacteria (bacteria in supernatant) after 2 hs infection in RAW264.7 cells in the presence or absence of N-acetyl-l-cystein (NAC), a reactive oxygen species inhibitor.
*Indicated significant at P < 0.05. (C) Differentially secreted proteins were found in regular SDS-PAGE gels and confirmed by Western blotting. (D) Differentially
secreted supernatant protein profiles detected by 2DE. Red and Green arrows indicate some upregulated or down-regulated proteins in the wide-type or 1VirD4
strains compared between the two gels that were used for LC/MS.
TABLE 1 | Summarization of differentially secreted proteins between
wild-type and 1VirD4 strains separated on the two-dimensional PAGE
gels.
Cells No. of protein
spots showing
changes
1.5- to 3-fold
changes
3- to 5-fold
changes
>5 fold
changes
>10000*
fold
change
WT 33 14 5 3 11
1VirD4 148 91 29 12 16
* indicates presence of the protein spots only in the wild-type or 1VirD4 strain.
the first line of host defense. Phagocytosis-associated respiratory
burst would generate antimicrobial reactive oxygen species
(ROS) including superoxide anion (O•−2 ), hydrogen peroxide
(H2O2), and hydroxyl radical (•OH) (Forman and Torres, 2002;
Fang et al., 2015; Zheng et al., 2016). We attempted an in vitro
oxidative stress assay using non-lethal dose of hydrogen peroxide
to mimic host-bacteria interaction in vivo to examine if such
exposure would affect expression of virD4 itself and hence the
release of secreted proteins. We did find significantly higher
expression of virD4 mRNA in SS2 not only upon H2O2 stress
but also upon phagocytosis, suggesting that it might be an
in vivo induced gene. Such oxidative stress also led to differential
expression of secreted proteins betweenWT and1VirD4 strains.
The protein spots with a >3-fold abundance change due to
H2O2 stress were subjected to MALDI-TOF/MS analysis. Results
showed that ten proteins identified are involved in DNA damage
repair, nucleotide biosynthesis, carbohydrate metabolism and
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TABLE 2 | Identification and qualification of differentially secreted proteins between wild-type and 1VirD4 strains selected for LC/MS and qPCR.
Spotsa Proteins identified Score % coverage Matched
Peptides
Locus tag
(05ZYH33)
Protein change
in abundanceb
Change in
mRNA level
B13 Parvulin-like peptidyl-prolyl isomerase (PrsA) 102 18 6 SSU05_1238 8.8 1.5
B14 115 21 7 3.8
B31 Succinate dehydrogenase/fumarate reductase (SucD) 198 32 8 SSU05_2153 10000 1.7
B33 Glycerate-dependent phosphoglycerate mutase (GpmA) 295 33 8 SSU05_1638 9.7 1.4
A20 Ribonucleoside-diphosphate reductase (RNR) 541 32 25 SSU05_1207 7.8 27
A39 6-phospho-beta-galactosidase (LacG) 464 27 13 SSU05_1036 10000 30
A120 Uracil phosphoribosyltransferase (UPP) 354 57 14 SSU05_1553 12.2 13
A132 Galactose-6-phosphate isomerase subunit (LacB) 218 50 10 SSU05_1042 10000 68
A143 Arginine deiminase (arcA) 514 50 26 SSU05_0624 3.7 1.6
A146 Ornithine carbamoyltransferase (arcB) 348 56 24 SSU05_0626 5.0 2.2
A148 Tagatose-bisphosphate aldolase (LacD) 422 49 12 SSU05_1040 10000 102
a B or A means these spot numbers were from differential expressed proteins in the wild-type strain or ∆VirD4 mutant, respectively as shown in Figure 4C.
b The number “10000” means that these proteins were present only in wild-type or 1irD4 strain.
FIGURE 5 | Verification of more secretion of PrsA protein in wide-type strain as compared with its 1VirD4 mutant after hydrogen peroxide treatment.
(A) Prokaryotic expression and purification of PrsA protein by SDS-PAGE. Lane 1, E. coli cell lysate from culture without IPTG induction; Lane 2, E. coli cell lysate from
IPTG-induced culture; Lane 3, purified PrsA proteins, Lane 4, molecular weight markers. (B) Western blotting of Lane 1 and Lane 3 of (A) using anti-His monoclonal
antibody. (C,D) Secretion of PrsA protein in the culture supernatant samples of the wild-type S. suis type 2 strain and its 1VirD4 mutant after hydrogen peroxide
treatment by Western blot (C) and ELISA (D) using the rabbit anti-PrsA polyclonal antibodies for probing. WT-H or 1VirD4-H means the wild-type or 1VirD4 strain
were treated with 10mM H2O2. *Indicated significant at P < 0.05. The arrows in (A) indicate two possible isoforms of PrsA [same for (C)].
stress modulation reported in S. suis or other bacteria. These
secreted proteins with currently unknown mechanisms could
be termed as moonlighting proteins that function not only in
catalytic or metabolic activities but also act as modulators in
bacterial virulence (Henderson and Martin, 2011, 2013).
The PrsA protein secreted abundantly in WT strain, but
not in 1VirD4 mutant, was selected for further evaluation of
its functions. Because prokaryotes and eukaryotes are known
to have three ubiquitously distributed enzymes known as
cyclophilins, FK506 binding proteins (FKBPs), and parvulins,
which catalyze the cis/trans isomerization of peptide bonds
preceding prolyl residues, thereby assisting protein folding at
the post-translocational level (Ünal and Steinert, 2014; Nath
and Isakov, 2015). We found that SS2-PrsA expressed in E. coli
showed dose-dependent cytotoxicity with significant cell death at
concentrations above 75 µg/ml. At a non-cytotoxic dose of 10
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FIGURE 6 | PrsA protein showed dose-dependent cytotoxicity but without hemolytic activity. (A) Fluorescent observation of live (green) and dead (red)
bEND3.0 cells treated with PrsA at different concentrations for 1 h. Triton X-100 (0.2%) and 1640 medium treatments were used as positive and negative controls. Bar
scales indicated were 100 µm. (B) Evaluation of cytotoxicity with lactodehydrogenase (LDH) release assay kit. Cells were treated as panel A for 1 h or 2 hs. (C)
Hemolysis analysis with 2% sheep red blood cells treated with PrsA (50 and 100 µg/ml) for 1 h at 37◦C. Triton X-100 (0.2%), His-tag (100 µg/ml) and BSA (100 µg/ml)
proteins were used as controls. Absorbance values of the supernatant samples from the above treatments were measured at 540 nm. Data were shown as mean ±
SD of three replicate wells of each treatment. **Indicated significant at P < 0.01.
µg/ml, PrsA induced significant expression of IL-1β and TNF-α
in murine macrophage cell line RAW264.7. These results suggest
that PrsA may contribute to the pathogenicity of S. suis type 2,
as its counterparts in other bacterial species that function in a
number of biological processes, such as colonization or invasion,
protease exportation, immune activation and cells apoptosis
(Ünal and Steinert, 2014). In gram-positive bacteria, PrsA is
the only general factor mediating folding of secreted proteins
essential for bacterial pathogenicity and cell wall biosynthesis
(Sarvas et al., 2004). In S. pneumoniae, PpmA, a surface-
associated homology of the parvulin protein, was demonstrated
to contribute to pneumococcal pathogenesis since PpmA gene
deletion reduced bacterial persistence in mice nasopharynx and
enhanced bacterial uptake by macrophages (Cron et al., 2009). In
Listeria monocytogenes, PrsA2 plays a critical role in folding of
virulence factors, cell wall biosynthesis and resistance to osmotic
stress (Alonzo and Freitag, 2010; Cahoon and Freitag, 2014).
The parvulin peptidyl-prolyl isomeraseHP0175 in gram-negative
Helicobacter pylori induces apoptosis of gastric epithelial cells and
modulates the inflammatory response during infection (Basak
et al., 2005; Kundu, 2013).
Taken together, we demonstrate that VirD4 is antiphagocytic
and its expression increases upon oxidative stress or
phagocytosis. PrsA is cytotoxic and proinflammatory, and
its expression is dependent on VirD4. We suppose that there
might be complex relationship between PrsA and VirD4 and
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FIGURE 7 | PrsA protein induced pro-inflammatory cytokine responses in murine macrophage cells. (A–C) Relative mRNA levels of proinflammatory
cytokines IL-1β, IL-6 and TNF-α as determined by qPCR. The results were presented as fold induction relative to non-infected cells against β-actin gene expression
using 2−11Ct method. RAW264.7 cells were stimulated by PrsA (10 µg/ml) for 1 h, 3 hs, 6 hs, and 10 hs, respectively. Lipopolysaccharide (LPS) was used at
400 ng/ml as controls. (D,E) Levels of IL-1β and TNF-α in the culture supernatants of cells treated with PrsA as determined by ELISA. All experiments were repeated
three times with similar trends. Data were shown as mean ± SD of three replicate wells of one typical treatment. “*” or “**” indicated significant at P < 0.05 or
P < 0.01, respectively.
their expression upon oxidative stress during respiratory burst,
between VirD4 and phagocytosis, and between PrsA and
cytotoxicity in in vivo conditions. Further research is required to
examine if VirD4 has direct effects as an antiphagocytic protein
or results from increased expression of PrsA that exerts cytotoxic
effects to debilitate the phagocytic function. The roles of putative
SS2-T4SS in PrsA secretion and the possible mechanisms of PrsA
in inducing cells death and proinflammatory response are also
worth investigation.
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